Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 153 No. 1 (2023)

Procedures of brain death diagnosis and organ explantation in a tertiary medical centre – a retrospective eight-year cohort study

  • Pascale Grzonka
  • Sira M. Baumann
  • Kai Tisljar
  • Sabina Hunziker
  • Stephan Marsch
  • Raoul Sutter
DOI
https://doi.org/10.57187/smw.2023.40029
Cite this as:
Swiss Med Wkly. 2023;153:40029
Published
23.01.2023

Summary

AIMS OF THE STUDY: To assess the frequency and variables associated with the need for ancillary tests to confirm suspected brain death in adult patients, and to assess the time from brain death to organ explantation in donors. We further sought to identify modifiable factors influencing the time between brain death and start of surgery.

METHODS: Medical records and the Swiss organ allocation system registry were screened for all consecutive adult patients diagnosed with brain death at an intensive care unit of a Swiss tertiary medical centre from 2013 to 2020. The frequency and variables associated with the performance of ancillary tests (i.e., transcranial doppler, digital subtraction angiography, and computed tomography angiography) to confirm brain death were primary outcomes; the time from death to organ explantation as well as modifying factors were defined as secondary outcomes.

RESULTS: Among 91 patients with a diagnosis of brain death, 15 were not explanted and did not undergo further ancillary tests. Of the remaining 76 patients, who became organ donors after brain death, ancillary tests were performed in 24%, most frequently in patients with hypoxic-ischaemic encephalopathy. The leading presumed causes of death (not mutually exclusive) were haemorrhagic strokes (49%), hypoxic-ischaemic encephalopathies (33%) and severe traumatic brain injuries (22%). Surgery for organ explantation was started within a median of 16 hours (interquartile range [IQR] 13–18) after death with delay increasing over time (nonparametric test for trend p = 0.05), mainly due to organ allocation procedures. Patients with brain death confirmed during night shifts were explanted earlier (during night shifts 14.3 hours, IQR 11.8–16.8 vs 16.3 hours, IQR 13.5–18.5 during day shifts; p = 0.05).

CONCLUSIONS: Ancillary tests to confirm brain death are frequently performed, mainly in resuscitated patients. The delay to surgery for organ explantation after confirmed brain death was longer during day shifts, increased over time and was mainly determined by organ allocation procedures.

The trial was registered on clinical trials.gov (identifier: NCT03984981)

References

  1. Powner DJ, Hernandez M, Rives TE. Variability among hospital policies for determining brain death in adults. Crit Care Med. 2004 Jun;32(6):1284–8. https://doi.org/10.1097/01.CCM.0000127265.62431.0D DOI: https://doi.org/10.1097/01.CCM.0000127265.62431.0D
  2. Wahlster S, Wijdicks EF, Patel PV, Greer DM, Hemphill JC 3rd, Carone M, et al. Brain death declaration: practices and perceptions worldwide. Neurology. 2015 May;84(18):1870–9. https://doi.org/10.1212/WNL.0000000000001540 DOI: https://doi.org/10.1212/WNL.0000000000001540
  3. Greer DM, Wang HH, Robinson JD, Varelas PN, Henderson GV, Wijdicks EF. Variability of Brain Death Policies in the United States. JAMA Neurol. 2016 Feb;73(2):213–8. https://doi.org/10.1001/jamaneurol.2015.3943 DOI: https://doi.org/10.1001/jamaneurol.2015.3943
  4. Junn A, Hwang DY. Practice Variability in Determination of Death by Neurologic Criteria for Adult Patients. Yale J Biol Med. 2019 Dec;92(4):719–24.
  5. Greer DM, Shemie SD, Lewis A, Torrance S, Varelas P, Goldenberg FD, et al. Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death Project. JAMA. 2020 Sep;324(11):1078–97. https://doi.org/10.1001/jama.2020.11586 DOI: https://doi.org/10.1001/jama.2020.11586
  6. De Georgia MA. History of brain death as death: 1968 to the present. J Crit Care. 2014 Aug;29(4):673–8. https://doi.org/10.1016/j.jcrc.2014.04.015 DOI: https://doi.org/10.1016/j.jcrc.2014.04.015
  7. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007 Oct;370(9596):1453–7. https://doi.org/10.1016/S0140-6736(07)61602-X DOI: https://doi.org/10.1016/S0140-6736(07)61602-X
  8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83. https://doi.org/10.1016/0021-9681(87)90171-8 DOI: https://doi.org/10.1016/0021-9681(87)90171-8
  9. Grzonka P, Tisljar K, Rüegg S, Marsch S, Sutter R. What to exclude when brain death is suspected. J Crit Care. 2019 Oct;53:212–7. https://doi.org/10.1016/j.jcrc.2019.06.030 DOI: https://doi.org/10.1016/j.jcrc.2019.06.030
  10. Cuzick J. A Wilcoxon-type test for trend. Stat Med. 1985;4(1):87–90. https://doi.org/10.1002/sim.4780040112 DOI: https://doi.org/10.1002/sim.4780040112
  11. Welschehold S, Boor S, Reuland K, Thömke F, Kerz T, Reuland A, et al. Technical aids in the diagnosis of brain death: a comparison of SEP, AEP, EEG, TCD and CT angiography. Dtsch Arztebl Int. 2012 Sep;109(39):624–30. DOI: https://doi.org/10.3238/arztebl.2012.0624
  12. Taylor T, Dineen RA, Gardiner DC, Buss CH, Howatson A, Pace NL. Computed tomography (CT) angiography for confirmation of the clinical diagnosis of brain death. Cochrane Database Syst Rev. 2014 Mar;2014(3):CD009694. https://doi.org/10.1002/14651858.CD009694.pub2 DOI: https://doi.org/10.1002/14651858.CD009694.pub2
  13. Greer DM, Varelas PN, Haque S, Wijdicks EF. Variability of brain death determination guidelines in leading US neurologic institutions. Neurology. 2008 Jan;70(4):284–9. https://doi.org/10.1212/01.wnl.0000296278.59487.c2 DOI: https://doi.org/10.1212/01.wnl.0000296278.59487.c2

Most read articles by the same author(s)